U.S. markets close in 3 hours 44 minutes
  • S&P 500

    4,291.27
    +11.12 (+0.26%)
     
  • Dow 30

    33,885.34
    +124.29 (+0.37%)
     
  • Nasdaq

    13,104.96
    +57.77 (+0.44%)
     
  • Russell 2000

    2,012.07
    -4.54 (-0.23%)
     
  • Crude Oil

    88.63
    -3.46 (-3.76%)
     
  • Gold

    1,795.40
    -20.10 (-1.11%)
     
  • Silver

    20.26
    -0.43 (-2.09%)
     
  • EUR/USD

    1.0178
    -0.0079 (-0.77%)
     
  • 10-Yr Bond

    2.7820
    -0.0670 (-2.35%)
     
  • GBP/USD

    1.2074
    -0.0065 (-0.53%)
     
  • USD/JPY

    133.2170
    -0.2630 (-0.20%)
     
  • BTC-USD

    24,261.34
    -256.73 (-1.05%)
     
  • CMC Crypto 200

    576.61
    -14.15 (-2.39%)
     
  • FTSE 100

    7,509.15
    +8.26 (+0.11%)
     
  • Nikkei 225

    28,871.78
    +324.80 (+1.14%)
     

MultiPlan Reports Record Fourth Quarter and Full Year 2021 Results

  • Oops!
    Something went wrong.
    Please try again later.
·20 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Q4 2021 Revenues of $298.3 million, Net Income of $24.9 million and Adjusted EBITDA of $223.6 million

Full Year 2021 Revenues of $1,117.6 million, Net Income of $102.1 million and Adjusted EBITDA of $838.3 million

Growth driven by increased volumes and strong savings performance across all lines of business resulting in increased potential medical cost savings of 17% over 2020; 9% adjusted for HST acquisition

Full Year 2022 revenue guidance of $1,160 million to $1,200 million and Adjusted EBITDA guidance of $850 million to $875 million

NEW YORK, February 17, 2022--(BUSINESS WIRE)--MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the fourth quarter and full year ended December 31, 2021.

"We are incredibly proud of the critical role MultiPlan continues to play in the U.S. healthcare system, generating billions of dollars in savings for payors, employers and consumers. The fourth quarter of 2021 was the capstone on one of the most successful years in MultiPlan’s history, during which we set new records in savings for our customers and delivered exceptional growth, demonstrating the strength and resiliency of our business model in a challenging operating environment," said Dale White, CEO of MultiPlan. "Our operating assets and platform, deep domain knowledge, extensive connectivity and customizable capabilities reinforce our unique value in the marketplace and offer a significant competitive advantage as we continue to invest to grow our business and meet the changing needs of our customers."

The Company remains focused on its mission of delivering affordability, efficiency and fairness to the U.S. healthcare system and driving sustained long-term growth by enhancing its existing product offerings, extending into new payor customer segments, and expanding its market-leading platform to include new business models that deliver value-added services for providers, payors and healthcare consumers.

Business and Financial Highlights

  • Revenues of $298.3 million for Q4 2021, an increase of 16.8% over Q4 2020 revenues of $255.3 million.

  • Net income of $24.9 million for Q4 2021, compared to net loss of $173.3 million for Q4 2020.

  • Adjusted EBITDA of $223.6 million for Q4 2021, compared to $195.1 million for Q4 2020.

  • Revenues of $1,117.6 million for full year 2021, an increase of 19.2% over full year 2020 revenues of $937.8 million for full year.

  • Net income for full year 2021 of $102.1 million compared to net loss of $520.6 million for full year 2020.

  • Adjusted EBITDA of $838.3 million for full year 2021, compared to $706.3 million for full year 2020.

  • Net cash provided by operating activities of $404.7 million for full year 2021, compared to $377.4 million for full year 2020.

  • Free Cash Flow of $320.1 million for full year 2021, compared to $306.6 million for full year 2020.

  • The Company processed $32.2 billion in claims during the fourth quarter 2021, identifying potential medical cost savings of approximately $5.7 billion. For the year ended December 31, 2021, the Company processed approximately $120.7 billion in claims and identified approximately $21.7 billion in potential medical cost savings compared to $101.7 billion claims and approximately $18.6 billion in potential medical cost savings for the year ended December 31, 2020.

The fourth quarter 2021 results reflect an estimated COVID-related revenue impact of $5-7 million and an estimated COVID-related Adjusted EBITDA impact of $4-6 million, as compared to an estimated COVID-related revenue impact of $12-16 million and an estimated COVID-related Adjusted EBITDA impact of $12-14 million in Q4 2020.

The full year 2021 results reflect an estimated COVID-related revenue impact of $40-50 million and an estimated COVID-related Adjusted EBITDA impact of $32-40 million, as compared to an estimated COVID-related revenue impact of $100-110 million and an estimated COVID-related Adjusted EBITDA impact of $80-90 million for full year 2020.

2022 Financial Guidance

Financial Metric

Full Year 2022 Guidance

Revenues

$1,160 million to $1,200 million

Adj. EBITDA

$850 million to $875 million

Cash flow from operations

$380 million to $420 million

Capital expenditures

$90 million to $100 million

Interest expense

$280 million to $290 million

Depreciation

$65 million to $70 million

Amortization of intangible assets

$335 million to $345 million

Effective tax rate

25% to 28%

The above annual guidance assumes an estimated COVID-related revenue impact of approximately $25-30 million and an estimated COVID-related Adjusted EBITDA impact of approximately $20-24 million for full year 2022. The Company anticipates Q1 2022 revenues between $280 million and $295 million and Adjusted EBITDA between $210 million and $220 million.

The Company will host a conference call today, Thursday, February 17, 2022 at 8:00 a.m. U.S. Eastern Time (ET) to discuss its financial results. To access the conference call, please register using the link below:

https://www.incommglobalevents.com/registration/q4inc/9727/multiplan-corporation-fourth-quarter-2021-earnings-conference-call/

A live webcast of the conference call can be accessed through the Investor Relations section of the Company’s website at investors.multiplan.com/events-and-presentations. Participants should join the webcast ten minutes prior to the start of the conference call. A supplemental slide deck will also be available on this section of the MultiPlan website.

For those unable to listen to the live conference call, an audio replay will be available approximately two hours after the call through the archived webcast on the Investor Relations section of the Company’s website or by dialing (866) 813-9403 or (929) 458-6194. The replay access code is 32573.

About MultiPlan

MultiPlan is a leading provider of data analytics and technology-enable solutions designed to bring affordability, efficiency and fairness to the U.S. healthcare industry. We do so through services focused on reducing medical cost and improving billing and payment accuracy for the payors of healthcare, which are health insurers, self-insured employers and other health plan sponsors (typically through their health plan administrators), and, indirectly, the plan members who are the consumers of healthcare services. For more information, visit multiplan.com.

Forward-Looking Statements

This press release includes statements that express our and our subsidiaries’ opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements". These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "forecasts," "intends," "plans," "may," "will" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this press release, including the discussion of 2022 outlook, guidance and impact of The No Surprises Act, and these forward-looking statements reflect management’s expectations regarding our future growth, results of operations, operational and financial performance and business prospects and opportunities. Such forward-looking statements are based on available current market material and management’s expectations, beliefs and forecasts concerning future events impacting the business. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect our actual financial results, including: the impact from the COVID-19 pandemic and its related effects on our projected results of operations, financial performance or other financial metrics; loss of our customers, particularly our largest customers; decreases in our existing market share or the size of our Preferred Provider Organization networks; effects of competition; effects of pricing pressure; the inability of our customers to pay for our services; decreases in discounts from providers; the loss of our existing relationships with providers; the loss of key members of our management team; pressure to limit access to preferred provider networks; the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected; our ability to identify, complete and successfully integrate acquisitions; changes in our industry; interruptions or security breaches of our information technology systems; our ability to protect proprietary applications; our inability to expand our network infrastructure; our ability to remediate any material weakness or maintain effective internal controls over financial reporting; changes in our regulatory environment, including healthcare law and regulations; the expansion of privacy and security laws; heightened enforcement activity by government agencies; our ability to pay interest and principal on our notes and other indebtedness; the possibility that we may be adversely affected by other political, economic, business, and/or competitive factors; other factors disclosed in our Securities and Exchange Commission ("SEC") filings; and other factors beyond our control.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021, including those under "Risk Factors" therein, and other documents filed or to be filed with the SEC by us. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Forward-looking statements speak only as of the date made. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this press release contains certain non-GAAP financial measures, including EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and Adjusted cash conversion ratio. A non-GAAP financial measure is generally defined as a numerical measure of a company’s financial or operating performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP.

EBITDA, Adjusted EBITDA, Free Cash Flow, Unlevered Free Cash Flow and Adjusted cash conversion ratio are supplemental measures of MultiPlan’s performance that are not required by or presented in accordance with GAAP. These measures are not measurements of our financial or operating performance under GAAP, have limitations as analytical tools and should not be considered in isolation or as an alternative to net income (loss), cash flows or any other measures of performance prepared in accordance with GAAP.

EBITDA represents net income (loss) before interest expense, interest income, income tax provision (benefit), depreciation, amortization of intangible assets, and non-income taxes. Adjusted EBITDA is EBITDA as further adjusted by certain items as described in the table below.

In addition, in evaluating EBITDA and Adjusted EBITDA you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of EBITDA and Adjusted EBITDA. The presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. The calculations of EBITDA and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. Based on our industry and debt financing experience, we believe that EBITDA and Adjusted EBITDA are customarily used by investors, analysts and other interested parties to provide useful information regarding a company’s ability to service and/or incur indebtedness.

We also believe that Adjusted EBITDA is useful to investors and analysts in assessing our operating performance during the periods these charges were incurred on a consistent basis with the periods during which these charges were not incurred. Both EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider either in isolation, or as a substitute for analysis of our results as reported under GAAP. Some of the limitations are:

  • EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;

  • EBITDA and Adjusted EBITDA do not reflect interest expense, or the cash requirements necessary to service interest or principal payments on our debt;

  • ​EBITDA and Adjusted EBITDA do not reflect our tax expense or the cash requirements to pay our taxes; and

  • ​Although depreciation and amortization are non-cash charges, the tangible assets being depreciated will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements.

​MultiPlan’s presentation of Adjusted EBITDA should not be construed as an inference that our future results and financial position will be unaffected by unusual items.

Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, all as disclosed in the Statements of Cash Flows. Unlevered Free Cash Flow is defined as net cash provided by operating activities less capital expenditures, plus cash interest paid, all as disclosed in the Statements of Cash Flows. Free Cash Flow and Unlevered Free Cash Flow are measures of our operational performance used by management to evaluate our business after purchases of property and equipment and, in the case of Unlevered Free Cash Flow, prior to the impact of our capital structure. Free Cash Flow and Unlevered Free Cash Flow should be considered in addition to, rather than as a substitute for, consolidated net income as a measure of our performance and net cash provided by operating activities as a measure of our liquidity. Additionally, MultiPlan’s definitions of Free Cash Flow and Unlevered Free Cash Flow are limited, in that they do not represent residual cash flows available for discretionary expenditures, due to the fact that the measures do not deduct the payments required for debt service, in the case of Unlevered Free Cash Flow, and other contractual obligations or payments made for business acquisitions.

Adjusted cash conversion ratio is defined as Unlevered Free Cash Flow divided by Adjusted EBITDA. MultiPlan believes that the presentation of the Adjusted cash conversion ratio provides useful information to investors because it is a financial performance measure that shows how much of its Adjusted EBITDA MultiPlan converts into Unlevered Free Cash Flow.

We have not reconciled the forward-looking Adjusted EBITDA guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses (including expenses relating to the business combination), certain fair value measurements and costs related to the uncertainties caused by the global COVID-19 pandemic, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

MULTIPLAN CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)

December 31,

2021

2020

Assets

Current assets:

Cash and cash equivalents

$

185,328

$

126,755

Restricted cash

3,051

Trade accounts receivable, net

99,905

63,198

Prepaid expenses

24,910

17,708

Prepaid taxes

5,064

Other current assets, net

999

1,193

Total current assets

319,257

208,854

Property and equipment, net

213,238

187,631

Operating lease right-of-use assets

30,104

31,339

Goodwill

4,363,070

4,257,336

Other intangibles, net

3,285,037

3,584,187

Other assets

9,701

14,231

Total assets

$

8,220,407

$

8,283,578

Liabilities and Shareholders’ Equity

Current liabilities:

Accounts payable

$

13,005

$

15,261

Accrued interest

55,685

31,528

Accrued taxes

10,176

Operating lease obligation, short-term

6,883

6,439

Current portion of long-term debt

13,250

Accrued compensation

25,419

21,843

Other accrued expenses

27,666

27,251

Total current liabilities

141,908

112,498

Long-term debt

4,879,144

4,578,488

Operating lease obligation, long-term

26,725

27,499

Private Placement Warrants and unvested founder shares

74,000

106,595

Deferred income taxes

753,825

900,633

Other liabilities

135

Total liabilities

5,875,737

5,725,713

Commitments and contingencies (Note 13)

Shareholders’ equity:

Shareholder interests

Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued

Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 665,456,180 and 664,183,318 issued; 638,338,774 and 655,075,355 shares outstanding

67

66

Additional paid-in capital

2,311,660

2,530,410

Retained earnings

225,112

116,999

Treasury stock — 27,117,406 and 9,107,963 shares

(192,169

)

(89,610

)

Total shareholders’ equity

2,344,670

2,557,865

Total liabilities and shareholders’ equity

$

8,220,407

$

8,283,578

MULTIPLAN CORPORATION

Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)

(in thousands, except share and per share data)

Years Ended December 31,

2021

2020

2019

Revenues

$

1,117,602

$

937,763

$

982,901

Costs of services (exclusive of depreciation and amortization of intangible assets shown below)

175,292

318,675

149,607

General and administrative expenses

151,095

355,635

75,225

Depreciation

64,885

60,577

55,807

Amortization of intangible assets

340,210

334,697

334,053

Total expenses

731,482

1,069,584

614,692

Operating income (loss)

386,120

(131,821

)

368,209

Interest expense

267,475

335,638

376,346

Interest income

(30

)

(288

)

(196

)

Loss (gain) on extinguishment of debt

15,843

102,993

(18,450

)

(Gain) loss on investments

(25

)

12,165

Change in fair value of Private Placement Warrants and unvested founder shares

(32,596

)

(35,422

)

Net income (loss) before taxes

135,453

(546,907

)

10,509

Provision (benefit) for income taxes

33,373

(26,343

)

799

Net income (loss)

$

102,080

$

(520,564

)

$

9,710

Weighted average shares outstanding – Basic(1)

651,006,567

470,785,192

415,700,000

Weighted average shares outstanding – Diluted

651,525,791

470,785,192

415,700,000

Net income (loss) per share – Basic

$

0.16

$

(1.11

)

$

0.02

Net income (loss) per share – Diluted

$

0.16

$

(1.11

)

$

0.02

Comprehensive income (loss)

$

102,080

$

(520,564

)

$

9,710

1 In accordance with the accounting guidance, the number of shares outstanding prior to the business combination of Polaris Parent Corp. and Churchill Capital Corp III (the "Transactions") was 415,700,000, which represents the 10 historical shares of Polaris Parent Corp. multiplied by the exchange ratio established in the Transactions (41,570,000:1). At the date of the Transactions, the number of shares outstanding increased to 655,057,192. The increase represents the shares issued by Churchill Capital Corp III prior to the Transactions and the shares issued to PIPE investors at the time of the Transactions, net of shares redeemed and held in treasury upon closing.

MULTIPLAN CORPORATION

Consolidated Statements of Cash Flows

(in thousands)

Years Ended December 31,

2021

2020

2019

Operating activities:

Net income (loss)

$

102,080

$

(520,564

)

$

9,710

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation

64,885

60,577

55,807

Amortization of intangible assets

340,210

334,697

334,053

Amortization of the right-of-use asset

6,963

8,405

9,594

Stock-based compensation

18,010

406,054

(14,880

)

Deferred income taxes

(81,929

)

(45,041

)

(111,404

)

Non-cash interest costs

12,259

22,888

13,368

Loss on extinguishment of debt

15,843

102,993

(18,450

)

Loss on equity investments

12,165

Loss on disposal of property and equipment

2,991

610

163

Change in fair value of Private Placement Warrants and unvested founder shares

(32,596

)

(35,422

)

Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions:

Accounts receivable, net

(33,826

)

14,758

5,279

Prepaid expenses and other assets

(6,952

)

(7,480

)

(8,822

)

Prepaid taxes

(5,064

)

2,130

(1,426

)

Operating lease obligation

(5,900

)

(8,461

)

(9,462

)

Accounts payable and accrued expenses and other

7,713

29,065

20,783

Net cash provided by operating activities

404,687

377,374

284,313

Investing activities:

Purchases of property and equipment

(84,590

)

(70,813

)

(66,414

)

Proceeds from sale of investment

5,641

Purchase of equity investments

HST Acquisition, net of cash acquired

246

(140,032

)

DHP Acquisition, net of cash acquired

(149,676

)

Net cash used in investing activities

(228,379

)

(210,845

)

(66,414

)

Financing activities:

Repayments of Term Loan G

(2,341,000

)

(369,000

)

(100,000

)

Extinguishment of 7.125% Notes

(1,615,583

)

Extinguishment of Senior PIK Notes

(1,202,302

)

(101,013

)

Issuance of Senior Convertible PIK Notes

1,267,500

Issuance of 5.750% Notes

1,300,000

Repayments of Term Loan B

(3,313

)

Issuance of Term Loan B

1,298,930

Issuance of 5.50% Senior Secured Notes

1,034,520

Taxes paid on settlement of vested share awards

(3,789

)

Borrowings on revolving credit facility

98,000

Repayment of revolving credit facility

(98,000

)

Effect of the Transactions

682,408

MULTIPLAN CORPORATION

Consolidated Statements of Cash Flows Continued

(in thousands)

Years Ended December 31,

2021

2020

2019

Purchase of treasury stock

(100,000

)

(101,123

)

Payment of debt issuance costs

(23,489

)

Borrowings on finance leases, net

(32

)

(10

)

(75

)

Net cash used in financing activities

(114,684

)

(61,599

)

(201,088

)

Net increase in cash, cash equivalents and restricted cash

61,624

104,930

16,811

Cash, cash equivalents and restricted cash at beginning of period

126,755

21,825

5,014

Cash, cash equivalents and restricted cash at end of period

$

188,379

$

126,755

$

21,825

Cash and cash equivalents

$

185,328

$

126,755

$

21,825

Restricted cash

3,051

Cash, cash equivalents and restricted cash at end of period

$

188,379

$

126,755

$

21,825

Noncash investing and financing activities:

Purchases of property and equipment not yet paid

$

5,930

$

4,334

$

3,768

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

$

6,880

$

10,210

$

4,000

Supplemental disclosure of cash flow information:

Cash paid during the period for:

Interest

$

(231,049

)

$

(312,349

)

$

(363,907

)

Income taxes, net of refunds

$

(131,517

)

$

(3,917

)

$

(114,569

)

MULTIPLAN CORPORATION

Calculation of EBITDA and Adjusted EBITDA

(in thousands)

Year Ended December 31,

2021

2020

2019

Net income (loss)

$

102,080

$

(520,564

)

$

9,710

Adjustments:

Interest expense

267,475

335,638

376,346

Interest income

(30

)

(288

)

(196

)

Income tax provision (benefit)

33,373

(26,343

)

799

Depreciation

64,885

60,577

55,807

Amortization of intangible assets

340,210

334,697

334,053

Non-income taxes

1,698

3,221

1,944

EBITDA

$

809,691

$

186,938

$

778,463

Adjustments:

Other expenses

8,295

1,095

1,947

Integration expenses

9,460

801

Change in fair value of Private Placement Warrants and unvested founder shares

(32,596

)

(35,422

)

Transaction-related expenses

9,647

31,689

3,270

(Gain) loss on investments

(25

)

12,165

Loss (gain) on extinguishment of debt

15,843

102,993

(18,450

)

Stock-based compensation

18,010

406,054

(14,880

)

Adjusted EBITDA

$

838,325

$

706,313

$

750,350

Calculation of Free Cash Flow, Unlevered Free Cash Flow and Adjusted Cash Conversion Ratio

(in thousands)

Year Ended December 31,

2021

2020

2019

Net cash provided by operating activities

$

404,687

$

377,374

$

284,313

Purchases of property and equipment

(84,590

)

(70,813

)

(66,414

)

Free Cash Flow

320,097

306,561

217,899

Interest paid

231,049

312,349

363,907

Unlevered Free Cash Flow

$

551,146

$

618,910

$

581,806

Adjusted EBITDA

$

838,325

$

706,313

$

750,350

Adjusted Cash Conversion Ratio

66

%

88

%

78

%

Net cash used in investing activities

$

(228,379

)

$

(210,845

)

$

(66,414

)

Net cash used in financing activities

$

(114,684

)

$

(61,599

)

$

(201,088

)

View source version on businesswire.com: https://www.businesswire.com/news/home/20220217005278/en/

Contacts

Investor Relations
Luke Montgomery, CFA
SVP, Finance & Investor Relations
MultiPlan
866-909-7427
investor@multiplan.com

Shawna Gasik
AVP, Investor Relations
MultiPlan
866-909-7427
investor@multiplan.com

Media Relations
Pamela Walker
Senior Director, Marketing & Communications
MultiPlan
781-895-3118
press@multiplan.com